We have Known It To assess whether previous research on purported risk or protective factors for Alzheimer's disease (AD) and cognitive decline is of sufficient strength to warrant specific recommendations…
November is Alzheimer's Awareness Month, a time to heighten awareness about Alzheimer's disease and show support for the more than 6.2 million Americans living with it. Quick Stats: There are over 6…
Focused Ultrasound Therapy Focused ultrasound is a noninvasive, therapeutic technology with the potential to improve the quality of life and decrease the cost of care for patients with Alzheimer’s disease.…
Myth 1: Memory loss is a natural part of aging. Reality: As people age, it's normal to have occasional memory problems, such as forgetting the name of a person you've…
The FDA recently approved a second drug to treat early-stage Alzheimer’s. It’s called Kisunla and was developed by the company Eli Lilly. In Alzheimer’s patients, brain proteins form plaques and tangles in…
The proportion of ethnic minorities among the elderly in the United States is increasing. The U.S. Census Bureau estimates that the proportion of elders who are white and non-Hispanic will…
A degree of mobility loss is expected with age, but certain conditions can accelerate this pattern. Specifically, Alzheimer’s disease and other forms of dementia can result in slower movements and…
Researchers do not know the exact cause of Alzheimer’s disease, but it likely is due to a variety of genetic and environmental factors. The most studied of the environmental factors…
Growing evidence has shown that inflammation could be a hallmark contributor to AD development and exacerbation. Pro-inflammatory cytokines like TNF-α, IL-1β, and IL-6 are upregulated in brains of individuals with…
According to one associate research professor at the University of Nevada, Las Vegas, and the lead researcher of this study, most people are surprised that their gut bacteria could affect…